These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25640522)

  • 1. Pediatric ovarian neoplastic tumors: incidence, age at presentation, tumor markers and outcome.
    Taskinen S; Fagerholm R; Lohi J; Taskinen M
    Acta Obstet Gynecol Scand; 2015 Apr; 94(4):425-9. PubMed ID: 25640522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian masses in children and adolescents - an analysis of 521 clinical cases.
    Zhang M; Jiang W; Li G; Xu C
    J Pediatr Adolesc Gynecol; 2014 Jun; 27(3):e73-7. PubMed ID: 24157281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian germ cell tumours: a 17-year study in a single unit.
    Panteli C; Curry J; Kiely E; Pierro A; de Coppi P; Anderson J; Sebire N; Drake D
    Eur J Pediatr Surg; 2009 Apr; 19(2):96-100. PubMed ID: 19360543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant ovarian germ cell tumors: clinico-pathological presentation and survival outcomes.
    Tangjitgamol S; Hanprasertpong J; Manusirivithaya S; Wootipoom V; Thavaramara T; Buhachat R
    Acta Obstet Gynecol Scand; 2010; 89(2):182-9. PubMed ID: 19961281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selecting treatment method for ovarian masses in children - 24 years of experience.
    Łuczak J; Bagłaj M
    J Ovarian Res; 2017 Sep; 10(1):59. PubMed ID: 28893324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue AP-2gamma and Oct-3/4, and serum CA 125 as diagnostic and prognostic markers of malignant ovarian germ cell tumors.
    Salonen J; Leminen A; Stenman UH; Butzow R; Heikinheimo M; Heikinheimo O
    Tumour Biol; 2008; 29(1):50-6. PubMed ID: 18497549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor markers in mature cystic teratomas of the ovary.
    Ustunyurt E; Gungor T; Iskender C; Ustunyurt BO; Bilge U; Mollamahmutoglu L
    Arch Gynecol Obstet; 2009 Feb; 279(2):145-7. PubMed ID: 18506458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
    Engelen MJ; de Bruijn HW; Hollema H; ten Hoor KA; Willemse PH; Aalders JG; van der Zee AG
    Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of serum levels of tumor markers with tissue expression of gene products in ovarian carcinoma.
    Sorak M; Arsenijević S; Lukić G; Arsenijević N; Ristić P; Pavlović S; Popović S; Baskić D
    J BUON; 2007; 12(1):99-104. PubMed ID: 17436409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can we preoperatively risk stratify ovarian masses for malignancy?
    Oltmann SC; Garcia N; Barber R; Huang R; Hicks B; Fischer A
    J Pediatr Surg; 2010 Jan; 45(1):130-4. PubMed ID: 20105592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgery for ovarian masses in infants, children, and adolescents: 102 consecutive patients treated in a 15-year period.
    Cass DL; Hawkins E; Brandt ML; Chintagumpala M; Bloss RS; Milewicz AL; Minifee PK; Wesson DE; Nuchtern JG
    J Pediatr Surg; 2001 May; 36(5):693-9. PubMed ID: 11329568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian malignant mixed germ cell tumor with clear cell carcinoma in a postmenopausal woman.
    Yu XJ; Zhang L; Liu ZP; Shi YQ; Liu YX
    Int J Clin Exp Pathol; 2014; 7(12):8996-9001. PubMed ID: 25674278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian germ cell tumors in children. Management, survival and ovarian prognosis. A report of 75 cases.
    Vaysse C; Delsol M; Carfagna L; Bouali O; Combelles S; Lemasson F; Le Mandat A; Castex MP; Pasquet M; Moscovici J; Guitard J; Pienkowski C; Rubie H; Galinier P; Vaysse P
    J Pediatr Surg; 2010 Jul; 45(7):1484-90. PubMed ID: 20638529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transumbilical 1-port laparoscopic resection of benign ovarian tumor.
    Lee SY; Lee HM; Kao CY; Chuang JH
    J Pediatr Surg; 2012 Jul; 47(7):1340-4. PubMed ID: 22813793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-operative differentiation of pediatric ovarian tumors: morphological scoring system and tumor markers.
    Stankovic ZB; Djukic MK; Savic D; Lukac BJ; Djuricic S; Sedlecki K; Zdravkovic D
    J Pediatr Endocrinol Metab; 2006 Oct; 19(10):1231-8. PubMed ID: 17172084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management and outcomes of ovarian masses in children and adolescents.
    Islam S; Yamout SZ; Gosche JR
    Am Surg; 2008 Nov; 74(11):1062-5. PubMed ID: 19062661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ovarian growing teratoma syndrome clinical study of 22 cases].
    Cheng NH; Huang HF; Lian LJ; Wu Y
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jun; 44(6):426-30. PubMed ID: 19953942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor markers CA 125 and CA 19-9 in cord blood and during infancy: developmental changes and use in pediatric germ cell tumors.
    Lahdenne P; Pitkänen S; Rajantie J; Kuusela P; Siimes MA; Lanning M; Heikinheimo M
    Pediatr Res; 1995 Nov; 38(5):797-801. PubMed ID: 8552451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant ovarian germ cell tumors: identification of novel prognostic markers and long-term outcome after multimodality treatment.
    Murugaesu N; Schmid P; Dancey G; Agarwal R; Holden L; McNeish I; Savage PM; Newlands ES; Rustin GJ; Seckl MJ
    J Clin Oncol; 2006 Oct; 24(30):4862-6. PubMed ID: 17050871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.